Net Investment Income (NII) for Q4 2025 was $0.31 per share, representing over 50% quarter-over-quarter growth. GAAP Net Asset Value (NAV) was $8.07 per share as of December 31, 2025, while Pro Forma NAV, reflecting the incentive fee waiver, was $8.23 per share. The Investment Adviser waived all accrued incentive fees as of December 31, 2025, totaling approximately $2.3 million or $0.16 per share, and also waived Q1 2026 incentive fees. Matthew A. Drapkin resigned as Chairman of the Board, effective immediately following the filing of the 2025 Form 10-K. Jason W. Reese was appointed Executive Chairman of the Board, effective immediately after Mr. Drapkin's resignation. The Board declared a $0.30 per share distribution for Q1 2026, equating to a 19.2% annualized dividend yield as of February 27, 2026. The company repurchased $18.7 million of GECCO notes due June 2026 to date, with $38.8 million remaining outstanding as of February 27, 2026. A call notice was issued for $20 million of GECCO notes to be redeemed on March 31, 2026. Total investment income for Q4 2025 was $12.6 million, an increase from $10.6 million in Q3 2025. Net assets decreased to $112.9 million ($8.07 per share) as of December 31, 2025, from $140.1 million ($10.01 per share) as of September 30, 2025, with unrealized losses comprising over half of this change. The asset coverage ratio was 158.1% as of December 31, 2025, down from 168.2% in the prior quarter, with a pro forma ratio of 166.0% reflecting the incentive fee waiver and called notes. Net realized and unrealized losses for Q4 2025 totaled approximately $26.4 million, or $1.88 per share. A stock repurchase program was authorized, allowing the company to opportunistically repurchase up to $10 million of its common shares. Chris Croteau was hired as Head of Research, strengthening the investment platform.